Inventor
GABATHULER REINHARD
US23 patents
⚠️ This page may combine multiple inventors who share the name “GABATHULER REINHARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BIOASIS TECHNOLOGIES INC
10 patentsUS9364567B2Jun 14, 2016
Fragments of p97 and uses thereof
BIOASIS TECHNOLOGIES INC25 citations93
US9993530B2Jun 12, 2018
Fragments of P97 and uses thereof
BIOASIS TECHNOLOGIES INC8 citations82
US9932565B2Apr 3, 2018
Dephosphorylated lysosomal storage disease proteins and methods of use thereof
BIOASIS TECHNOLOGIES INC7 citations82
US9850472B2Dec 26, 2017
P97-antibody conjugates and methods of use
BIOASIS TECHNOLOGIES INC8 citations82
US10772939B2Sep 15, 2020
Fragments of P97 and uses thereof
BIOASIS TECHNOLOGIES INC3 citations71
US11643454B2May 9, 2023
P97 fusion proteins
BIOASIS TECHNOLOGIES INC0 citations61
US11124781B2Sep 21, 2021
P97-IDS fusion proteins
BIOASIS TECHNOLOGIES INC0 citations61
US11034943B2Jun 15, 2021
Dephosphorylated lysosomal storage disease proteins and methods of use thereof
BIOASIS TECHNOLOGIES INC0 citations61
US10392605B2Aug 27, 2019
P97-IDS fusion proteins
BIOASIS TECHNOLOGIES INC1 citations61
US10058619B2Aug 28, 2018
P97-polynucleotide conjugates
BIOASIS TECHNOLOGIES INC1 citations50
UNIV BRITISH COLUMBIA
4 patentsUS6361770B1Mar 26, 2002
Method of enhancing expression of MHC class I molecules bearing endogenous peptides
UNIV BRITISH COLUMBIA6 citations68
US5792604AAug 11, 1998
Method of identifying MHC-class I restricted antigens endogenously processed by cellular secretory pathway
UNIV BRITISH COLUMBIA8 citations68
US12077582B2Sep 3, 2024
Antibodies to L-type voltage gated channels and related methods
UNIV BRITISH COLUMBIA0 citations51
US11492400B2Nov 8, 2022
Antibodies to L-type voltage gated channels and related methods
UNIV BRITISH COLUMBIA1 citations51
CAVA HEALTHCARE INC
3 patentsUS12011421B2Jun 18, 2024
Curcuphenol compounds for increasing MHC-I expression
CAVA HEALTHCARE INC0 citations58
US11197832B2Dec 14, 2021
Curcuphenol compounds for increasing MHC-I expression
CAVA HEALTHCARE INC0 citations58
US10751296B2Aug 25, 2020
Curcuphenol compounds for increasing MHC-I expression
CAVA HEALTHCARE INC0 citations47
RAPTOR PHARMACEUTICAL INC
2 patentsUS7560431B2Jul 14, 2009
Methods of increasing delivery of active agents to brain comprising administering receptor associated protein (RAP) fragments conjugated to active agents
RAPTOR PHARMACEUTICAL INC16 citations90
US7977317B2Jul 12, 2011
Compositions and methods for modulating blood-brain barrier transport
RAPTOR PHARMACEUTICAL INC4 citations60